The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world (rw) treatment (tx) patterns and clinical outcomes among patients (pts) with metastatic urothelial carcinoma (mUC) receiving first-line (1L) systemic tx and avelumab 1L maintenance (1LM): Results from the IMPACT UC-III study.
 
Helen Moon
Honoraria - EMD Serono (Inst); Pfizer/EMD Serono (Inst); Pfizer/NCCN (Inst)
Research Funding - Amgen (Inst); Apollomics (Inst); Arcus Biosciences (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); HUYA Bioscience International (Inst); Nektar (Inst); Pfizer (Inst); Prometheus; Revimmune (Inst); Seagen (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Aveo; Bayer; Genentech; Seagen
 
Chiemeka Ike
Employment - EMD Serono
Stock and Other Ownership Interests - Merck
 
Valerie A. Morris
Employment - EMD Serono
Stock and Other Ownership Interests - Merck
 
Ruth Wangia Dixon
Employment - Carelon Research
Research Funding - Merck (Inst)
 
Ivy Tonnu-Mihara
Employment - Carelon Research
Research Funding - Merck (Inst)
 
Christopher L. Crowe
Employment - Carelon Research
Consulting or Advisory Role - Merck (Inst)
 
Malvika Venkataraman
Employment - Carelon Research
Research Funding - Merck (Inst)
 
Mairead Kearney
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck; Novartis; U.S. Department of Veterans Affairs
 
John Barron
Employment - Carelon Research
Research Funding - Merck